Drug reference
Treatment of mild to moderate ulcerative colitis, acute attack ▶BY MOUTH ▶Adult: 2.25 g 3 times a day until remission occurs or for up to maximum of 12 weeks Maintenance of remission of ulcerative colitis ▶BY MOUTH ▶Adult: 1.5 g twice daily (max. per dose 3 g), adjusted according to response; maximum 6 g per day
PDF page 66
History of asthma
PDF page 66
→Appendix 1: balsalazide
PDF page 66
Blood disorder. cholelithiasis. lupus-like syndrome
PDF page 66
Manufacturer advises avoid.
PDF page 66
Diarrhoea may develop in the infant. Monitoring Monitor breast-fed infants for diarrhoea.
PDF page 66
Manufacturer advises caution; avoid in severe impairment (no information available).
PDF page 66
Manufacturer advises avoid in moderate to severe impairment.
PDF page 66
There can be variation in the licensing of different medicines containing the same drug. Capsule CAUTIONARY AND ADVISORY LABELS 21, 25 ▶Colazide (Almirall Ltd) Balsalazide disodium 750 mg Colazide 750mg capsules | 130 capsule P £30.42 DT = £30.42 eiiii F 44
PDF page 67
2.25 g 3 times a day until remission occurs or for
First-line fragment. Read the complete Indications and Dose section above.
PDF page 66
1.5 g twice daily (max. per dose 3 g), adjusted
First-line fragment. Read the complete Indications and Dose section above.
PDF page 66
